BATS BZX Real-Time Price
As of 2:59pm ET
| +0.52 / +0.15%|
The 27 analysts offering 12-month price forecasts for Biogen have a median target of 338.00, with a high estimate of 395.00 and a low estimate of 277.00. The median estimate represents a -2.03% decrease from the last price of 344.99.
The current consensus among 31 polled investment analysts is to Buy stock in Biogen. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.